Trial Site Detail
Drug: |
Sunitinib + TH-302 |
|||
|---|---|---|---|---|
Trial: |
Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma and Gastrointestinal Stromal Tumors (TH-CR-410) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Unknown |
|||
Indiana University Simon Cancer Center535 Barnhill Drive |
Principal Investigator: |
Theodore Logan, MD |
|---|---|
Contact: |
Matthew Hinman mghinman@indiana.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Indiana University Simon Cancer Center Website: |
http://cancer.iu.edu/cancer/trials/findtrials.php?category=disease |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.